SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 30.22 |
| Enterprise Value ($M) | 20.66 |
| Book Value ($M) | 7.07 |
| Book Value / Share | 0.29 |
| Price / Book | 4.27 |
| NCAV ($M) | 7.07 |
| NCAV / Share | 0.29 |
| Price / NCAV | 4.27 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.30 |
| Return on Assets (ROA) | -2.60 |
| Return on Equity (ROE) | -1,527.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.66 |
| Current Ratio | 5.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.03 |
| Assets | 10.03 |
| Liabilities | 2.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,030 | 28,527 | 31.65 | |
| 9,838 | 51,232 | 19.20 | |
| 23,610 | 102,469 | 23.04 | |
| 21,162 | 164,115 | 12.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RGLS – Regulus Therapeutics Inc. | RMTI – Rockwell Medical, Inc. |
| RNAZ – TransCode Therapeutics, Inc. | RVPH – Reviva Pharmaceuticals Holdings, Inc. |
| RZLT – Rezolute, Inc. |
Financial data and stock pages provided by
Fintel.io